— Know what they know.
Not Investment Advice

IVRO OTC

InVitro International
1W: +0.0% 1M: -14.3% 3M: -29.7% YTD: -39.9% 1Y: +0.0% 3Y: -17.2% 5Y: -60.0%
$0.06
-0.01 (-7.69%)
 
Weekly Expected Move ±10.6%
$0 $0 $0 $0 $0
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 47 · $1.3M mcap · 16M float · 0.115% daily turnover · Short 76% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.3M
52W Range0.0315-0.16
Volume1,000
Avg Volume17,874
Beta-0.83
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOW. Richard Ulmer
Employees5
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date1991-05-16
330 East Orangethorpe Avenue
Placentia, CA 92870
US
949-851-8356
About InVitro International

Established in 1985 and headquartered in Placentia, California, InVitro International specializes in creating and supplying non-animal testing kits to markets both within the United States and globally. Key among their offerings is the Irritection Assay System, an in vitro diagnostic tool designed to identify, categorize, and forecast the potential for eye and skin irritation across a broad spectrum of items, including cosmetics, general consumer products, pharmaceuticals, and various chemical raw materials. They also provide Corrositex, another in vitro test specifically for determining chemical corrosiveness. Beyond product sales, the company delivers tailored technological support for the implementation and use of the Irritection system, alongside offering independent laboratory services for irritation and corrosion assessments. Their solutions are predominantly adopted by manufacturers involved in producing surfactants, petrochemicals, cosmetics, textiles, paper and pulp, pharmaceuticals, films and resins, solvents and cleaners, and other chemical raw materials.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms